| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/19/2007 | US20070167372 Ocular tear growth factor-like protein |
| 07/19/2007 | US20070167371 Treating deficient tear output and enhancing the proliferation of human corneal epithelial cells by contacting the ocular surface or the cells with a lacrimal gland protein that has activity as a growth factor on both human corneal epithelial cells and on the lacrimal acinar cells that produce it. |
| 07/19/2007 | US20070167370 Peptide analogues of GIP for treatment of diapetes, insulin resistance and obesity |
| 07/19/2007 | US20070167369 Novel use of isolated polypeptide comprising four FAS-1 domains, EM1 domain and RGD motif |
| 07/19/2007 | US20070167365 Compositions and methods for modulating blood-brain barrier transport |
| 07/19/2007 | US20070167363 Peptide fragments and optionally excipients, used for prophylaxis of obesity and non-insulin dependent diabetes; antagonist of glucose-dependent insulinotropic polypeptide (GIP) consisting of a 24 amino acid polypeptide corresponding to positions 7-30 of the sequence of GIP |
| 07/19/2007 | US20070167356 Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof |
| 07/19/2007 | US20070167351 Peptide/Lipid Complex Formation by Co-Lyphilization |
| 07/19/2007 | US20070167350 Quinaldine based semisquaraines and squaraine dyes, process for preparation thereof and use thereof |
| 07/19/2007 | US20070166824 Manipulation of non-terminally differentiated cells using the notch pathway |
| 07/19/2007 | US20070166820 Alphavirus replicons and helper constructs |
| 07/19/2007 | US20070166796 Il-21 antagonists |
| 07/19/2007 | US20070166795 Cytokine-like proteins |
| 07/19/2007 | US20070166794 Cytokine zalpha11 ligand fusion proteins |
| 07/19/2007 | US20070166792 Increasing hemoglobin and other heme protein production in bacteria by co-expression of heme transport genes |
| 07/19/2007 | US20070166790 Derivatives of magainin and methods of production thereof |
| 07/19/2007 | US20070166787 Modulators of regulatory proteins |
| 07/19/2007 | US20070166786 Protein for use in generating resistance to bactericides in cells |
| 07/19/2007 | US20070166773 Compositions and methods for early pregnancy diagnosis |
| 07/19/2007 | US20070166756 Polypeptides and polynucleotides encoding same |
| 07/19/2007 | US20070166746 Human cytokine receptor |
| 07/19/2007 | US20070166737 Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy |
| 07/19/2007 | US20070166736 A nucleic acid encodes the polypeptide or fragment has ability to form a triple helix, form higher order collagen fibrils or fibers and provide tensile strenght or flexibility to muscle connective tissue, recognized by R34 antibody |
| 07/19/2007 | US20070166718 Diagnostic and therapeutic use of mal2 gene and protein for neurodegenerative diseases |
| 07/19/2007 | US20070166711 Juvenile hemochromatosis gene (hfe2a), expression products and uses thereof |
| 07/19/2007 | US20070166704 Identification of polynucleotides and polypeptide for predicting activity of compounds that interact with protein tyrosine kinases and/or protein tyrosine kinase pathways |
| 07/19/2007 | US20070166701 Methods for detecting flavivirus infection |
| 07/19/2007 | US20070166696 Adenovirus-transfected primary cells and methods of pathway mapping |
| 07/19/2007 | US20070166352 polyglycolic acid or polylactic acid or glycolic acid-lactic acid copolymer as biocompatible polymer having dispersed therein an active agent such as exendin-4; antidiabetic agent |
| 07/19/2007 | US20070166350 Compositions and methods for promoting attachment of cells of endothelial cell lineage to medical devices |
| 07/19/2007 | US20070166334 Coccidiosis Vaccines |
| 07/19/2007 | US20070166333 Method of antigen incorporation into neisseria bacterial outer membrane vesicles and resulting vaccine formulations |
| 07/19/2007 | US20070166332 A di-chain loop region modification comprising a Clostridial toxin substrate cleavage site from a SNARE protein within the di-chain loop region that is proteolytically cleaved by the enzymatic domain of the recombinantly modified Clostridial toxin; cell expression includes single to di-chain conversion |
| 07/19/2007 | US20070166331 Modified seb and prophylactics/remedies for immunopathy containing the same |
| 07/19/2007 | US20070166330 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 07/19/2007 | US20070166329 Containing transcriptional units which encode a signal sequence of one flavivirus and an immunogenic flavivirus antigen of a second flavivirus; Japanese encephalitis virus (JEV), West Nile virus (WNV) or related flaviviruses |
| 07/19/2007 | US20070166328 Genetic immunization against cervical carcinoma |
| 07/19/2007 | US20070166319 Human papilloma virus immunoreactive peptides |
| 07/19/2007 | US20070166318 Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins |
| 07/19/2007 | US20070166315 Vibrio cholerae o139 conjugate vaccines |
| 07/19/2007 | US20070166310 prostate cancer and benign prostatic hyperplasia; promote tissue regeneration and to facilitate wound healing |
| 07/19/2007 | US20070166287 Oncolytic virus |
| 07/19/2007 | US20070166283 Compositions and methods for the treatment of hemophilia a |
| 07/19/2007 | US20070166282 Homogeneous preparations of IL-28 and IL-29 |
| 07/19/2007 | US20070166278 Novel g-csf conjugates |
| 07/19/2007 | US20070166230 Ion channel |
| 07/19/2007 | DE102006001759A1 Synthesis of metal nanoparticles and nanocrystals, useful particularly for silver disinfection of e.g. medical instruments, uses a silicatein protein, also new silicateins and nucleic acid encoding them |
| 07/19/2007 | CA2637377A1 Template-fixed peptidomimetics with antimicrobial activity |
| 07/19/2007 | CA2637267A1 Novel nucleotide and amino acid sequences, and methods of use thereof for diagnosis |
| 07/19/2007 | CA2636891A1 Luminescent stem cells and uses thereof |
| 07/19/2007 | CA2636888A1 Luminescent transgenic non human animals, progeny, cell derivatives and uses thereof |
| 07/19/2007 | CA2636706A1 Protein c pathway associated polymorphisms as response predictors to activated protein c or protein c like compound administration |
| 07/19/2007 | CA2636633A1 Ace n-domain crystal |
| 07/19/2007 | CA2635996A1 Methods and compositions for treating asthma in human and non human primates |
| 07/19/2007 | CA2635724A1 Thermoreversible oil-in-water emulsion |
| 07/19/2007 | CA2634329A1 Octanoate-reduced human albumin |
| 07/19/2007 | CA2632872A1 Use of stomatin (stm1) polynucleotides for achieving a pathogen resistance in plants |
| 07/19/2007 | CA2631582A1 Enzymatic large-scale synthesis of mucin glycoconjugates, and immunogenic applications thereof |
| 07/19/2007 | CA2630220A1 Norovirus and sapovirus antigens |
| 07/19/2007 | CA2601803A1 Preventive or therapeutic agent and method for immune disease |
| 07/18/2007 | EP1808490A2 Genetically engineered bleb vaccine |
| 07/18/2007 | EP1808489A1 Expression system for Bacillus anthracis PA |
| 07/18/2007 | EP1808488A2 DNA sequences having anti-repressor activity |
| 07/18/2007 | EP1808485A2 Mutants of lactobacillus casei defective in carbon catabolism regulation |
| 07/18/2007 | EP1808445A2 A receptor protein tyrosine kinase |
| 07/18/2007 | EP1808444A1 Amyloid beta protein (globular assembly and usees thereof) |
| 07/18/2007 | EP1808443A1 Purified polypeptide comprising or consisting of a C-terminus MSP1 antigen from Plasmodium falciparum carrying a Glycosyl-phosphatidyl-inositol group (GPI) |
| 07/18/2007 | EP1808442A1 Enzymatic large-scale synthesis of mucin glyconjugates, and immunogenic applications thereof |
| 07/18/2007 | EP1808441A1 Luminescent stem cells, transgenic mammals and uses thereof |
| 07/18/2007 | EP1808439A2 Epiligrin, an epithelial ligand for integrins |
| 07/18/2007 | EP1808182A1 Lim mineralization protein splice variants |
| 07/18/2007 | EP1808180A2 Modified GP 100 and uses thereof |
| 07/18/2007 | EP1808179A2 Use of HSP20 for promoting wound healing and/or reducing scar formation |
| 07/18/2007 | EP1807515A2 Orthogonal translation components for the in vivo incorporation of unnatural amino acids |
| 07/18/2007 | EP1807512A2 Compositions and methods for reverse transcription |
| 07/18/2007 | EP1807504A1 Serum-free cell culture medium for mammalian cells |
| 07/18/2007 | EP1807449A2 Modified growth hormones |
| 07/18/2007 | EP1807448A2 Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses thereof |
| 07/18/2007 | EP1807447A2 Torc polynucleotides and polypeptides, and methods of use |
| 07/18/2007 | EP1807446A2 Immunogenic and therapeutic compositions for streptococcus pyogenes |
| 07/18/2007 | EP1807445A1 Method for producing l-amino acids using bacteria of the enterobacteriaceae family |
| 07/18/2007 | EP1807444A1 Pseudotyped baculovirus and its use |
| 07/18/2007 | EP1807110A2 Vaccine and nucleic acids capable of protecting poultry against colonisation by campylobacter |
| 07/18/2007 | EP1807107A2 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
| 07/18/2007 | EP1807106A2 Compositions and methods for treating disease |
| 07/18/2007 | EP1807099A2 Y2 selective receptor agonists for therapeutic interventions |
| 07/18/2007 | EP1572094A4 Sodium channel alpha subunit variants |
| 07/18/2007 | EP1558747A4 Glycoprotein synthesis |
| 07/18/2007 | EP1448781B1 Method for identifying target epitopes of the t cell mediated immune response and for assaying epitope-specific t cells |
| 07/18/2007 | EP1448772B1 Methods of increasing expression levels of human tnf receptor |
| 07/18/2007 | EP1319063B1 Method for in vitro propagation of the agent responsible for transmissible spongiform encephalopathies |
| 07/18/2007 | EP1285002B1 Regulating lipid levels via the zmax1 or hbm gene |
| 07/18/2007 | EP1284987B1 Methods for refolding proteins containing free cysteine residues |
| 07/18/2007 | EP1181043B1 Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus |
| 07/18/2007 | EP1098905B1 Rna helicases modulating translation termination |
| 07/18/2007 | EP1088077B1 Newcastle disease virus infectious clones, vaccines and diagnostic assays |
| 07/18/2007 | EP1040351B1 C-terminal region of agouti-related transcript (art) protein |
| 07/18/2007 | EP0981537B1 An infectious clone for human parainfluenza virus type 3 |
| 07/18/2007 | EP0860447B1 Hematopoietic stem cell growth factor (scgf) |
| 07/18/2007 | CN1327228C Method of identifying N-terminal proBNP |